| P2093 | author name string | Robert H Miller | |
| | Lianhua Bai | |
| P2860 | cites work | Docosahexaenoic acid and arachidonic acid are fundamental supplements for the induction of neuronal differentiation. | Q50703685 |
| | Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy. | Q50767537 |
| | Human mesenchymal stem cells signals regulate neural stem cell fate. | Q51091114 |
| | Animal serum-free culture conditions for isolation and expansion of multipotent mesenchymal stromal cells from human BM. | Q51116689 |
| | Bridging extra large defects of peripheral nerves: possibilities and limitations of alternative biological grafts from acellular muscle and Schwann cells. | Q51359847 |
| | Differential effects of Th1, monocyte/macrophage and Th2 cytokine mixtures on early gene expression for immune-related molecules by central nervous system mixed glial cell cultures. | Q51586474 |
| | Transdifferentiation of mesenchymal stem cells into Schwann cell-like myelinating cells. | Q51826959 |
| | Notch1 and Jagged1 are expressed after CNS demyelination, but are not a major rate-determining factor during remyelination. | Q52088310 |
| | Restoration of FcRgamma/Fyn signaling repairs central nervous system demyelination. | Q52576911 |
| | Immortalized rat Schwann cells produce tumours in vivo. | Q53521072 |
| | Gene transfer of insulin-like growth factor-I providing neuroprotection after spinal cord injury in rats. | Q53576653 |
| | Survival and migration of human and rat olfactory ensheathing cells in intact and injured spinal cord. | Q53635190 |
| | Mesenchymal stem cell-natural killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation. | Q53652498 |
| | A pilot study of recombinant insulin-like growth factor-1 in seven multiple sderosis patients. | Q54399172 |
| | Human mesenchymal stem cells express neural genes, suggesting a neural predisposition. | Q54604845 |
| | Endogenous leukemia inhibitory factor production limits autoimmune demyelination and oligodendrocyte loss | Q58425792 |
| | Myelin deficient mice: expression of myelin basic protein and generation of mice with varying levels of myelin | Q24313426 |
| | Myelin transcription factor 1 (Myt1) expression in demyelinated lesions of rodent and human CNS | Q24645412 |
| | Multilineage potential of adult human mesenchymal stem cells | Q27860737 |
| | The leading edge of stem cell therapeutics | Q28273636 |
| | Experimental allergic encephalomyelitis: a misleading model of multiple sclerosis | Q28284231 |
| | Human mesenchymal stem cells modulate allogeneic immune cell responses | Q28288692 |
| | OBSERVATIONS ON ATTEMPTS TO PRODUCE ACUTE DISSEMINATED ENCEPHALOMYELITIS IN MONKEYS | Q29543028 |
| | Marrow stromal cells as stem cells for nonhematopoietic tissues | Q29618770 |
| | Mesenchymal stem cells as trophic mediators | Q29619806 |
| | Detection of stromal cells in peripheral blood progenitor cell collections from breast cancer patients | Q30176460 |
| | Cell surface antigens on human marrow-derived mesenchymal cells are detected by monoclonal antibodies | Q30195546 |
| | The monoclonal antibody SH-2, raised against human mesenchymal stem cells, recognizes an epitope on endoglin (CD105). | Q30807148 |
| | Selection of poly-alpha 2,8-sialic acid mimotopes from a random phage peptide library and analysis of their bioactivity | Q31058914 |
| | Schwann cell-like differentiation by adult oligodendrocyte precursor cells following engraftment into the demyelinated spinal cord is BMP-dependent | Q33619015 |
| | The origin of remyelinating cells in the central nervous system | Q33699385 |
| | Axonal pathology in myelin disorders | Q33876742 |
| | Fetal and adult human oligodendrocyte progenitor cell isolates myelinate the congenitally dysmyelinated brain | Q34287449 |
| | Neurosphere-derived multipotent precursors promote neuroprotection by an immunomodulatory mechanism. | Q34433743 |
| | Remyelination of spinal cord axons by olfactory ensheathing cells and Schwann cells derived from a transgenic rat expressing alkaline phosphatase marker gene | Q34695869 |
| | Human bone marrow stromal cell treatment improves neurological functional recovery in EAE mice | Q46499204 |
| | Development and validation of an LC-MS/MS method for the quantitative determination of aripiprazole and its main metabolite, OPC-14857, in human plasma | Q46591483 |
| | Remyelination of dorsal column axons by endogenous Schwann cells restores the normal pattern of Nav1.6 and Kv1.2 at nodes of Ranvier | Q46990495 |
| | Cortical microinfarcts and demyelination significantly affect cognition in brain aging | Q47282832 |
| | Remyelination by transplanted oligodendrocytes of a demyelinated lesion in the spinal cord of the adult shiverer mouse | Q48087550 |
| | Olfactory ensheathing cells induce less host astrocyte response and chondroitin sulphate proteoglycan expression than Schwann cells following transplantation into adult CNS white matter | Q48135819 |
| | Transplantation of olfactory ensheathing cells fails to promote significant axonal regeneration from dorsal roots into the rat cervical cord. | Q48145021 |
| | Mesenchymal stem cells effectively modulate pathogenic immune response in experimental autoimmune encephalomyelitis | Q48227850 |
| | Behavioural consequences of oligodendrocyte progenitor cell transplantation into experimental demyelinating lesions in the rat spinal cord | Q48228550 |
| | Behavioral deficits in the cuprizone-induced murine model of demyelination/remyelination. | Q48265400 |
| | Enriched environment promotes adult neural progenitor cell mobilization in mouse demyelination models | Q48273782 |
| | The protease inhibitor, Bowman-Birk Inhibitor, suppresses experimental autoimmune encephalomyelitis: a potential oral therapy for multiple sclerosis | Q48293570 |
| | Oligodendrocyte progenitor cells derived from human embryonic stem cells express neurotrophic factors | Q48297921 |
| | Quantitative analysis of human endogenous retrovirus-W env in neuroinflammatory diseases. | Q48316367 |
| | Dissemination and proliferation of neural stem cells on the spinal cord by injection into the fourth ventricle of the rat: a method for cell transplantation | Q48329312 |
| | Injection of adult neurospheres induces recovery in a chronic model of multiple sclerosis | Q48332405 |
| | Notch1 and its ligand Jagged1 are present in remyelination in a T-cell- and antibody-mediated model of inflammatory demyelination. | Q48351890 |
| | Simvastatin regulates oligodendroglial process dynamics and survival. | Q48381524 |
| | Efficient induction of oligodendrocytes from human embryonic stem cells | Q48391796 |
| | Insulin-like growth factor binding proteins: regulation in chronic active plaques in multiple sclerosis and functional analysis of glial cells | Q48412149 |
| | Overexpression of a minor component of myelin basic protein isoform (17.2 kDa) can restore myelinogenesis in transgenic shiverer mice | Q48456326 |
| | Cryopreserved cells isolated from the adult canine olfactory bulb are capable of extensive remyelination following transplantation into the adult rat CNS. | Q48476797 |
| | A single intracerebral microinjection of platelet-derived growth factor (PDGF) accelerates the rate of remyelination in vivo | Q48727513 |
| | Remyelination of demyelinated CNS axons by transplanted human schwann cells: the deleterious effect of contaminating fibroblasts | Q48823771 |
| | Neural stem cells and neurospheres--re-evaluating the relationship | Q48919998 |
| | Quaking*jimpy double mutant mice: additional evidence for independence of primary deficits in jimpy | Q49049451 |
| | Fibroblast growth factor 2 induces loss of adult oligodendrocytes and myelin in vivo | Q49071724 |
| | Efficient myelin repair in the macaque spinal cord by autologous grafts of Schwann cells. | Q49084961 |
| | Teratoma formation leads to failure of treatment for type I diabetes using embryonic stem cell-derived insulin-producing cells | Q35083934 |
| | Embryonic stem cells differentiate into oligodendrocytes and myelinate in culture and after spinal cord transplantation | Q35761500 |
| | Insulin-like growth factor-1 fails to enhance central nervous system myelin repair during autoimmune demyelination | Q35829445 |
| | Neural stem cells as a potential source of oligodendrocytes for myelin repair | Q36134419 |
| | Stem cells in inflammatory demyelinating disorders: a dual role for immunosuppression and neuroprotection | Q36349552 |
| | RNA metabolism and dysmyelination in schizophrenia. | Q36381586 |
| | Promotion of remyelination by immunoglobulins: implications for the treatment of multiple sclerosis | Q36384922 |
| | Antigen presentation in autoimmunity and CNS inflammation: how T lymphocytes recognize the brain. | Q36506367 |
| | How to successfully apply animal studies in experimental allergic encephalomyelitis to research on multiple sclerosis | Q36520149 |
| | Antibodies as biological markers for pathophysiological processes in MS. | Q36578093 |
| | Potential role of humoral immunity in the pathogenesis of multiple sclerosis (MS) and experimental autoimmune encephalomyelitis (EAE). | Q36664209 |
| | Oligodendroglial abnormalities in schizophrenia, mood disorders and substance abuse. Comorbidity, shared traits, or molecular phenocopies? | Q36732735 |
| | Neural differentiation potential of peripheral blood- and bone-marrow-derived precursor cells. | Q37020047 |
| | Recombination within the myelin basic protein gene created the dysmyelinating shiverer mouse mutation | Q37402270 |
| | Multiple sclerosis: re-expression of a developmental pathway that restricts oligodendrocyte maturation | Q38362396 |
| | Labeled Schwann cell transplantation: cell loss, host Schwann cell replacement, and strategies to enhance survival. | Q38512427 |
| | Cell depletion due to diphtheria toxin fragment A after Cre-mediated recombination | Q39756881 |
| | Transplantation of undifferentiated murine embryonic stem cells in the heart: teratoma formation and immune response. | Q40173892 |
| | Transplantation of human neural stem cells exerts neuroprotection in a rat model of Parkinson's disease. | Q40202809 |
| | Neural transplantation of human MSC and NT2 cells in the twitcher mouse model. | Q40218374 |
| | Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells | Q40229749 |
| | An oligodendroglial progenitor cell line FBD-102b possibly secretes a radial glia-inducing factor | Q40248729 |
| | Serial in vivo MR tracking of magnetically labeled neural spheres transplanted in chronic EAE mice. | Q40257049 |
| | Multipotent neural stem cells from the adult tegmentum with dopaminergic potential develop essential properties of functional neurons | Q40363055 |
| | Targeted expression of IGF-1 in the central nervous system fails to protect mice from experimental autoimmune encephalomyelitis | Q40381732 |
| | Human embryonic stem cells differentiate into oligodendrocytes in high purity and myelinate after spinal cord transplantation | Q40493282 |
| | Human endogenous retrovirus glycoprotein-mediated induction of redox reactants causes oligodendrocyte death and demyelination | Q40510056 |
| | Glial cell line-derived neurotrophic factor-enriched bridging transplants promote propriospinal axonal regeneration and enhance myelination after spinal cord injury. | Q40627076 |
| | Neural progenitors from human embryonic stem cells. | Q40673316 |
| | Regulation of oligodendrocyte development and central nervous system myelination by insulin-like growth factors | Q40768915 |
| | Distinctive patterns of PDGF-A, FGF-2, IGF-I, and TGF-beta1 gene expression during remyelination of experimentally-induced spinal cord demyelination. | Q40792686 |
| | Embryonic stem cell-derived glial precursors: a source of myelinating transplants | Q40938819 |
| | Developmental appearance, antigenic profile, and proliferation of glial cells of the human embryonic spinal cord: an immunocytochemical study using dissociated cultured cells. | Q41092499 |
| | Regulation of oligodendrocyte development and CNS myelination by growth factors: prospects for therapy of demyelinating disease | Q41157691 |
| | Superantigens in demyelinating disease | Q41293469 |
| | Differential myelinogenic capacity of specific developmental stages of the oligodendrocyte lineage upon transplantation into hypomyelinating hosts | Q41588231 |
| | Enhancement of central nervous system remyelination in immune and non-immune experimental models of demyelination | Q41589686 |
| | Intraventricular transplantation of neural precursor cell spheres attenuates acute experimental allergic encephalomyelitis | Q42454885 |
| | PDGF and FGF2 pathways regulate distinct oligodendrocyte lineage responses in experimental demyelination with spontaneous remyelination | Q42815773 |
| | Neuronal nicotinic acetylcholine receptor expression by O2A/oligodendrocyte progenitor cells | Q43540969 |
| | Multiple sclerosis: altered glutamate homeostasis in lesions correlates with oligodendrocyte and axonal damage | Q43708042 |
| | In vitro differentiation of transplantable neural precursors from human embryonic stem cells | Q43814659 |
| | Ethidium bromide-induced demyelination of the sciatic nerve of adult Wistar rats. | Q43822774 |
| | Grafts of brain-derived neurotrophic factor and neurotrophin 3-transduced primate Schwann cells lead to functional recovery of the demyelinated mouse spinal cord. | Q43991306 |
| | Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation | Q44317237 |
| | Expression of a myelin basic protein gene in transgenic shiverer mice: correction of the dysmyelinating phenotype. | Q44381714 |
| | Interactions between human adipose stromal cells and mouse neural stem cells in vitro | Q44602743 |
| | Increasing local levels of neuregulin (glial growth factor‐2) by direct infusion into areas of demyelination does not alter remyelination in the rat CNS | Q44658194 |
| | Human neural stem cells improve sensorimotor deficits in the adult rat brain with experimental focal ischemia | Q44972813 |
| | Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness | Q45879145 |
| P433 | issue | 5 | |
| P304 | page(s) | 817-829 | |
| P577 | publication date | 2007-09-01 | |
| P1433 | published in | Regenerative Medicine | Q19921466 |
| P1476 | title | Cellular approaches for stimulating CNS remyelination | |
| P478 | volume | 2 | |